Biofil Chemicals & Pharmaceuticals Ltd

BIOFILCHEM

Watchlist

AI Mode

‌

Market Cap

₹ 57 Cr

P/E

19.89

‌

‌
‌

‌

‌
‌

Investment Checklist

How to read checklist?

Performance

UNDER PERFORMER

Valuation

REASONABLE

Growth

SLUGGISH

Profitability

HIGH MARGIN

Technicals

Bearish

Risk

LOW RISK

Investment Checklist

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

Price

PE Ratio

Price

‌

Overview

Detailed Summary

Biofil Chemicals & Pharmaceuticals Limited (BCPL) primarily manufactures and trades in pharmaceutical products, leveraging two divisions: Pharmaceuticals and Chemicals.

Initially a private company, BCPL transitioned to public status in 1992 and has since expanded into manufacturing a variety of pharmaceutical formulations, including injections and syrups.

A significant partnership with HLL Lifecare Limited has positioned BCPL as a key player in pharmaceutical manufacturing, especially for government contracts involving essential medications like Iron and Folic Acid tablets.

The company has diversified its operations by entering the plastic products market, primarily for pharmaceutical packaging, enhancing its vertical integration and sales offerings.

Sector

Pharmaceuticals

Industry

Pharmaceuticals - Indian - Formulations

Market Cap

57 Cr

Volatility

High Risk

P/E Ratio

19.9

Industry P/E

43.8

PEG Ratio

—

P/B Ratio

2.7

52W High

67.50

52W Low

32.60

Sales CAGR

-16.58%

14.28%

2.38%

10Y

10.89%

Profit CAGR

-21.13%

-7.22%

-14.31%

10Y

-3.69%

ROE

TTM

13.42%

3.37%

4.32%

10Y

5.57%

ROCE

TTM

15.83%

4.54%

6.24%

10Y

7.93%

Technicals

‌

Forecasts

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
MAKERSL	120.05	71 Cr	—	1.00	0.00	-0.03	8.67	2.48
KABRADG	27.01	65 Cr	54.82	2.50	0.00	4.59	5.90	2.18
BIOFILCHEM	33.75	57 Cr	19.89	2.67	0.00	13.42	15.83	5.15
VISTAPH	8.11	52 Cr	—	1.17	0.00	-15.00	-13.49	-10.99
SANDUPHQ	39.00	38 Cr	24.34	1.13	2.04	3.69	5.32	2.80
JFLLIFE	11.60	37 Cr	10.51	0.88	0.00	8.41	12.26	4.11
NIYATILEAS	18.55	37 Cr	80.35	1.63	0.00	2.04	2.92	1.35

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Standalone Quarterly Results (in ₹ Crores)

Total Figures

QoQ Changes

Total Figures

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Sales	2.43	17	5.03	15	8.44	2.41	14	8.35	6.43	14
Expenses	2.01	17	4.84	15	8.13	2.29	14	8.25	6.42	13
Operating Profit	0.42	0.24	0.19	-0.03	0.31	0.12	0.31	0.10	0.01	0.12
OPM %	17.28	1.38	3.78	-0.20	3.67	4.98	2.18	1.20	0.16	0.89
Other Income	0.02	0.03	0.03	0.41	0.03	0.02	0.02	0.24	2.83	0.06
Interest	0.01	0.01	0.00	0.02	0.01	0.01	0.01	0.01	0.01	0.00
Depreciation	0.11	0.11	0.11	0.08	0.10	0.10	0.10	0.08	0.07	0.07
Profit Before Tax	0.32	0.15	0.11	0.27	0.23	0.03	0.22	0.25	2.76	0.11
Tax %	25.00	20.00	18.18	11.11	26.09	33.33	27.27	20.00	12.68	27.27
Net Profit	0.24	0.12	0.09	0.25	0.17	0.02	0.16	0.20	2.41	0.08
EPS in Rs	0.15	0.08	0.06	0.15	0.10	0.01	0.10	0.12	1.48	0.05

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	13	12	23	30	36	22	30	40	33	31
Expenses	11	11	22	28	34	21	29	39	33	31
Operating Profit	2.62	0.93	1.02	1.82	1.60	1.33	1.17	0.82	0.85	0.54
OPM %	19.47	7.56	4.42	6.14	4.47	5.95	3.89	2.04	2.54	1.72
Other Income	0.14	0.10	0.10	0.17	0.80	0.15	0.10	0.49	0.31	3.11
Interest	0.16	0.15	0.16	0.12	0.07	0.04	0.04	0.04	0.04	0.04
Depreciation	0.28	0.30	0.37	0.41	0.41	0.43	0.43	0.40	0.38	0.35
Profit Before Tax	2.31	0.59	0.60	1.46	1.92	1.01	0.79	0.87	0.74	3.26
Tax %	22.34	19.98	19.39	17.55	35.31	31.19	29.33	18.04	24.22	14.42
Net Profit	1.79	0.47	0.48	1.21	1.24	0.70	0.56	0.71	0.56	2.79
EPS in Rs	1.11	0.29	0.29	0.76	0.76	0.44	0.29	0.44	0.33	1.75
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	16	16	16	16	16	16	16	16	16	16
Reserves	-5.37	-3.58	-3.11	-2.62	-1.39	-0.14	0.56	1.03	1.93	2.51
Borrowings	1.37	1.43	1.56	1.64	1.19	0.43	0.46	0.52	0.44	0.47
Other Liabilities	12	7.72	9.43	8.93	26	17	1.43	14	28	32
Total Liabilities	24	22	24	24	42	33	19	31	47	51
Fixed Assets	8.98	9.16	9.25	10	10	9.78	9.42	9.00	8.62	8.34
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	15	13	15	14	32	23	9.31	22	38	43
Total Assets	24	22	24	24	42	33	19	31	47	51

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	0.14	0.71	0.46	1.26	0.89	1.11	-0.22	-0.11	2.39	-1.92
Cash from Investing Activity	-0.19	-0.48	-0.38	-1.41	-0.21	-0.10	-0.07	-0.01	-0.02	-0.10
Cash from Financing Activity	0.10	-0.11	-0.02	-0.08	-0.57	-0.83	-0.01	0.02	-0.12	-0.00
Net Cash Flow	0.05	0.13	0.06	-0.24	0.12	0.18	-0.30	-0.11	2.25	-2.03

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Promoters	46.82%	46.82%	46.82%	46.82%	46.82%	46.82%	46.82%	46.82%	46.82%	46.82%	46.82%	46.79%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.03%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
DIIs	0.08%	0.08%	0.08%	0.08%	0.08%	0.08%	0.08%	0.08%	0.08%	0.08%	0.08%	0.08%
Public	53.10%	53.10%	53.10%	53.10%	53.10%	53.08%	53.10%	53.10%	53.10%	53.10%	53.10%	53.13%
Total Shareholders	28,378	27,475	26,741	26,123	25,864	26,581	25,480	26,422	26,114	25,914	25,685	25,196

Market Transactions

Date	Party	Category	Type	Avg Price (₹)	Total Value (₹)	Quantity	Percent Traded
Jun 10, 2025	Niyati shah	Insider - Promoter Group	Acquisition	—	—	4,93,940	3.02
Dec 18, 2024	Jayesh jagdishbhai hapani	Bulk	Sell	61.19	0.84 Cr	1,37,782	0.84
Sep 18, 2024	Anil shripal magdum huf	Bulk	Sell	84.75	0.79 Cr	92,900	0.57
Sep 16, 2024	Qe securities llp	Bulk	Sell	87.59	1.03 Cr	1,17,308	0.72
Sep 16, 2024	Qe securities llp	Bulk	Buy	87.41	1.02 Cr	1,16,429	0.71
Sep 13, 2024	Ankita vishal shah	Bulk	Buy	76.99	0.02 Cr	2,887	0.01
Sep 13, 2024	Marwadi chandarana intermedia...	Bulk	Sell	79.07	0.32 Cr	40,010	0.24
Sep 13, 2024	Marwadi chandarana intermedia...	Bulk	Buy	79.50	0.72 Cr	90,010	0.55
Sep 13, 2024	Ankita vishal shah	Bulk	Sell	79.50	1.61 Cr	2,02,887	1.24
Sep 13, 2024	Marwadi chandarana intermedia...	Bulk	Sell	77.99	0.79 Cr	1,01,076	0.62

Projection

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Sorry, no results found!

Documents

Presentations

Concalls

Reports

Presentations

No documents found!

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

AI Mode

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Standalone Quarterly Results (in ₹ Crores)

Total Figures

QoQ Changes

Total Figures

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Sales	2.43	17	5.03	15	8.44	2.41	14	8.35	6.43	14
Expenses	2.01	17	4.84	15	8.13	2.29	14	8.25	6.42	13
Operating Profit	0.42	0.24	0.19	-0.03	0.31	0.12	0.31	0.10	0.01	0.12
OPM %	17.28	1.38	3.78	-0.20	3.67	4.98	2.18	1.20	0.16	0.89
Other Income	0.02	0.03	0.03	0.41	0.03	0.02	0.02	0.24	2.83	0.06
Interest	0.01	0.01	0.00	0.02	0.01	0.01	0.01	0.01	0.01	0.00
Depreciation	0.11	0.11	0.11	0.08	0.10	0.10	0.10	0.08	0.07	0.07
Profit Before Tax	0.32	0.15	0.11	0.27	0.23	0.03	0.22	0.25	2.76	0.11
Tax %	25.00	20.00	18.18	11.11	26.09	33.33	27.27	20.00	12.68	27.27
Net Profit	0.24	0.12	0.09	0.25	0.17	0.02	0.16	0.20	2.41	0.08
EPS in Rs	0.15	0.08	0.06	0.15	0.10	0.01	0.10	0.12	1.48	0.05

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	13	12	23	30	36	22	30	40	33	31
Expenses	11	11	22	28	34	21	29	39	33	31
Operating Profit	2.62	0.93	1.02	1.82	1.60	1.33	1.17	0.82	0.85	0.54
OPM %	19.47	7.56	4.42	6.14	4.47	5.95	3.89	2.04	2.54	1.72
Other Income	0.14	0.10	0.10	0.17	0.80	0.15	0.10	0.49	0.31	3.11
Interest	0.16	0.15	0.16	0.12	0.07	0.04	0.04	0.04	0.04	0.04
Depreciation	0.28	0.30	0.37	0.41	0.41	0.43	0.43	0.40	0.38	0.35
Profit Before Tax	2.31	0.59	0.60	1.46	1.92	1.01	0.79	0.87	0.74	3.26
Tax %	22.34	19.98	19.39	17.55	35.31	31.19	29.33	18.04	24.22	14.42
Net Profit	1.79	0.47	0.48	1.21	1.24	0.70	0.56	0.71	0.56	2.79
EPS in Rs	1.11	0.29	0.29	0.76	0.76	0.44	0.29	0.44	0.33	1.75
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	16	16	16	16	16	16	16	16	16	16
Reserves	-5.37	-3.58	-3.11	-2.62	-1.39	-0.14	0.56	1.03	1.93	2.51
Borrowings	1.37	1.43	1.56	1.64	1.19	0.43	0.46	0.52	0.44	0.47
Other Liabilities	12	7.72	9.43	8.93	26	17	1.43	14	28	32
Total Liabilities	24	22	24	24	42	33	19	31	47	51
Fixed Assets	8.98	9.16	9.25	10	10	9.78	9.42	9.00	8.62	8.34
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	15	13	15	14	32	23	9.31	22	38	43
Total Assets	24	22	24	24	42	33	19	31	47	51

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	0.14	0.71	0.46	1.26	0.89	1.11	-0.22	-0.11	2.39	-1.92
Cash from Investing Activity	-0.19	-0.48	-0.38	-1.41	-0.21	-0.10	-0.07	-0.01	-0.02	-0.10
Cash from Financing Activity	0.10	-0.11	-0.02	-0.08	-0.57	-0.83	-0.01	0.02	-0.12	-0.00
Net Cash Flow	0.05	0.13	0.06	-0.24	0.12	0.18	-0.30	-0.11	2.25	-2.03

Oscillators

BearishNeutralBullish

Bullish

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bearish

Neutral

Bullish

Moving Averages

BearishNeutralBullish

Bearish

Neutral

Bullish

Overall

BearishNeutralBullish

Bearish

Neutral

Bullish

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
MAKERSL	120.05	71 Cr	—	1.00	0.00	-0.03	8.67	2.48
KABRADG	27.01	65 Cr	54.82	2.50	0.00	4.59	5.90	2.18
BIOFILCHEM	33.75	57 Cr	19.89	2.67	0.00	13.42	15.83	5.15
VISTAPH	8.11	52 Cr	—	1.17	0.00	-15.00	-13.49	-10.99
SANDUPHQ	39.00	38 Cr	24.34	1.13	2.04	3.69	5.32	2.80
JFLLIFE	11.60	37 Cr	10.51	0.88	0.00	8.41	12.26	4.11
NIYATILEAS	18.55	37 Cr	80.35	1.63	0.00	2.04	2.92	1.35

Overview

Detailed Summary

Biofil Chemicals & Pharmaceuticals Limited (BCPL) primarily manufactures and trades in pharmaceutical products, leveraging two divisions: Pharmaceuticals and Chemicals.

Initially a private company, BCPL transitioned to public status in 1992 and has since expanded into manufacturing a variety of pharmaceutical formulations, including injections and syrups.

The company has diversified its operations by entering the plastic products market, primarily for pharmaceutical packaging, enhancing its vertical integration and sales offerings.

Sector

Pharmaceuticals

Industry

Pharmaceuticals - Indian - Formulations

Market Cap

57 Cr

Volatility

High Risk

P/E Ratio

19.9

Industry P/E

43.8

PEG Ratio

—

P/B Ratio

2.7

52W High

67.50

52W Low

32.60

Sales CAGR

-16.58%

14.28%

2.38%

10Y

10.89%

Profit CAGR

-21.13%

-7.22%

-14.31%

10Y

-3.69%

ROE

TTM

13.42%

3.37%

4.32%

10Y

5.57%

ROCE

TTM

15.83%

4.54%

6.24%

10Y

7.93%